Key facts
- It has raised $110K; the latest was Early Stage VC in Oct 2025.
- Notable investors include Creative Destruction Lab, Invest Nova Scotia, New Brunswick Innovation Foundation, Elevate (Canada), Femtech Canada — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Elle, MD Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Elle, MD Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elle, MD Biotechnologies
Operator of a biotechnology company intended to develop a non-hormonal contraceptive device that prioritizes efficacy. The company provides contraceptive products designed to prevent pregnancy without affecting hormonal balance, enabling women to access a contraceptive option that supports reproductive health while maintaining overall well-being.
- Sector
- Healthcare
- HQ
- New Minas, Canada
- Founded
- 2022
- Employees
- 6
- Website
- ellemd.ca/
- Ownership
- Privately Held (backing)
Elle, MD Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elle, MD Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elle, MD Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.